Publications by authors named "Emma Magavern"

Claim this Profile
F
Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment.
Emma F Magavern, Gabriel Marengo, Maia Megase, Damian Smedley, Mark J Caulfield

Commun Med (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives.
Claire Moore, Emma F Magavern, Marliese Alexander, Safeera Y Hussainy, Tracey Danaher

Genet Med Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics of chronic dry cough unravels neurological pathways.
Kayesha Coley, Catherine John, Jonas Ghouse, David J Shepherd, Nick Shrine, Emma F Magavern

Eur Respir J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A United Kingdom nationally representative survey of public attitudes towards pharmacogenomics.
Emma F Magavern, Gabriel Marengo, , Chujan Sivathasan, Marta Mezzanzanica

QJM· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database.
Emma F Magavern, Maia Megase, Jack Thompson, Gabriel Marengo, Julius Jacobsen

PLoS Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study.
Emma F Magavern, Harshal Deshmukh, Geraldine Asselin, Elizabeth Theusch, Stella Trompet

Pharmacol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare disease gene association discovery in the 100,000 Genomes Project.
Valentina Cipriani, Letizia Vestito, Emma F Magavern, Julius O B Jacobsen, Gavin Arno

Nature· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of the UK Prescribing Safety Assessment as a component of undergraduate medical assessment.
David Hepburn, Andrew William Hitchings, Kurt Wilson, Lynne Bollington, Emma Magavern

Br J Clin Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?
Emma F Magavern, John H McDermott, Mark J Caulfield, William G Newman

Eur Heart J Cardiovasc Pharmacother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023.
Juan Tamargo, Stefan Agewall, Claudio Borghi, Claudio Ceconi, Elisabetta Cerbai, Emma Magavern

Eur Heart J Cardiovasc Pharmacother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy.
Emma F Magavern, Vikas Kapil, Manish Saxena, Ajay Gupta, Mark J Caulfield

Arterioscler Thromb Vasc Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment.
Emma F Magavern, Andrew Hitchings, Lynne Bollington, Kurt Wilson, David Hepburn

Br J Clin Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data.
Valentina Cipriani, Letizia Vestito, Emma F Magavern, Julius Ob Jacobsen, Gavin Arno

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohort.
Emma F Magavern, David A van Heel, , Damian Smedley, Mark J Caulfield

Br J Clin Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis.
Emma F Magavern, Faiza Durrani, Mehru Raza, Robin Lerner, Mohammed Riadul Islam

Pharmacogenomics J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort.
Emma F Magavern, , Damian Smedley, Mark J Caulfield

iScience· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort.
Emma F Magavern, David A van Heel, , Damian Smedley, Mark J Caulfield

Pharmacogenomics J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel.
Emma F Magavern, Benjamin Jacobs, Helen Warren, Gherardo Finocchiaro, Sarah Finer

JACC Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equal access to pharmacogenomics testing: The ethical imperative for population-wide access in the UK NHS.
Emma F Magavern, Mark J Caulfield

Br J Clin Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing direct-acting oral anticoagulants - Mind the evidence gap.
Elizabeth Adeyeye, Carmela Maniero, Emma F Magavern, Robin E Ferner, Patricia McGettigan

Br J Clin Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era.
Gherardo Finocchiaro, Emma F Magavern, Georgios Georgioupoulos, Niccolo' Maurizi, Gianfranco Sinagra

Heart Fail Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics: Relevance and opportunities for clinical pharmacology.
Richard M Turner, Emma F Magavern, Munir Pirmohamed

Br J Clin Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health equality, race and pharmacogenomics.
Emma F Magavern, Deepti Gurdasani, Fu L Ng, Sandra Soo-Jin Lee

Br J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Emma F Magavern, Juan Carlos Kaski, Richard M Turner, Heinz Drexel, Azara Janmohamed

Eur Heart J Cardiovasc Pharmacother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethics in clinical pharmacology: Facilitating public trust.
Emma F Magavern, Jan Piasecki, Adam Cohen, Serge Cremers

Br J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis